TRIFLUOPERAZINE vs LOW‐POTENCY ANTIPSYCHOTIC DRUGS
Response to treatment ‐ medium term · patients with schizophrenia
Trifluoperazine showed no clear difference in response to treatment ‐ medium term compared with low‐potency antipsychotic drugs (low certainty).
1 finding from 1 review
- Trifluoperazine versus low‐potency first‐generation antipsychotic drugs for schizophrenia 2014 · Cochrane Headline outcomes onlyRR 0.96 [0.59, 1.56]3 studies · 120 participantsLow